New Tests Launched in March

By Emily Linginfelter • April 4, 2019

Share this:

In March 2019, Mayo Clinic Laboratories announced six new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

New Tests

The new tests launched in March 2019 by Mayo Clinic Laboratories:

• • BCOR Immunostain, Technical Component Only (Mayo ID: BCOR)
  • Delta-Like 3 Protein (DDL3) (SP347), Semi-Quantitative Immunodistochemistry, Manual, Tissue (Mayo ID: DLL3)
  • Nonalcoholic Steatohepatitis (NASH)-FibroTest, Serum and Plasma (Mayo ID: NSFIB)
  • Nuclear Magnetic Resonance Lipoprotein Profile, Serum (Mayo ID: NMRLP)

Test Updates

In addition to these new tests, the department also announced several test changes. Click the links below to view test changes announced via Mayo Clinic Laboratories:

• All New Tests
• Test Changes
• Test Status Updates
• View All Updates

Emily Linginfelter

Emily Linginfelter is a Marketing Associate at Mayo Clinic Laboratories. She supports marketing strategies for product management and specialty testing. Emily has worked at Mayo Clinic since 2018.